Essentials: Diet & Nutrition for Mental Health | Dr. Chris Palmer

Episode Summary

Executive Summary: Andrew Huberman and Dr. Chris Palmer discuss how nutrition can meaningfully affect mental health, from mood and sleep to severe illnesses like depression, bipolar disorder, and schizophrenia. Palmer shares his own turnaround from metabolic syndrome and poor mood on Atkins, explains clinical cases where ketogenic diets produced dramatic psychiatric improvements, and argues that mitochondrial health may be a unifying mechanism linking diet, metabolism, and brain function.

Main Topics: Palmer’s personal history and shift toward metabolic psychiatry: Palmer describes his own childhood mental illness and later metabolic syndrome, then recounts how the Atkins diet reversed his prediabetes, blood pressure, lipids, and improved his mood, energy, concentration, and sleep. This experience shaped his clinical interest in nutrition as a psychiatric tool. Ketogenic diets as a treatment tool for mental illness: The conversation focuses on using ketogenic or carbohydrate-restricted diets for treatment-resistant mental disorders. Palmer emphasizes that diet is not a replacement for medication but a potentially powerful adjunct, especially when ketosis is achieved. Clinical case evidence from treatment-resistant patients: Palmer gives examples of patients with chronic depression and schizoaffective disorder who showed major improvements on ketogenic diets, including reduced hallucinations, improved functioning, weight loss, and reduced paranoia. Epilepsy as the historical foundation for ketogenic therapy: Huberman and Palmer review the century-long history of ketogenic diets in epilepsy, beginning with fasting observations and Wilder’s development of a diet that mimicked fasting to control seizures. This history provides scientific legitimacy for current psychiatric use. Mitochondria as a mechanistic bridge between diet and brain health: Palmer argues that ketogenic diets work partly by improving mitochondrial function through mitophagy and mitochondrial biogenesis, while also affecting neurotransmitters, inflammation, hormones, and gene expression. How much diet change is needed for different people: Palmer distinguishes between simple carbohydrate restriction for burnout or subclinical mood problems and full ketogenic therapy for severe psychiatric illness, noting that some patients may benefit just by removing junk food or lowering glucose/insulin.

Key Arguments: Nutrition can have direct, clinically meaningful effects on mental health, not merely indirect effects through weight or sleep. Ketosis appears important: Palmer observed that patients often improved only once they achieved urinary or blood ketones. For severe psychiatric disorders, ketogenic diets can produce medication-like or greater benefits in some patients, though not everyone responds. The ketogenic diet has a strong evidentiary precedent in epilepsy, where it was designed to mimic fasting and reduce seizures. Mitochondrial dysfunction may be a unifying mechanism across aging, inflammation, stress responses, and mental illness. Improving diet should not usually mean abruptly stopping psychiatric medication; medication changes require supervision. Highly processed, high-sugar, high-fat foods are likely especially harmful to both metabolic and mental health. Even non-ketogenic carbohydrate restriction may meaningfully improve mood, anxiety, and burnout in some people.

Data Points: Atkins trial duration: 3 months - Palmer says his metabolic syndrome resolved after three months on Atkins. Weight loss: ~10 pounds - Approximate weight loss during Palmer’s initial dietary change. Blood ketone target for depression: >0.8 mmol - Palmer’s suggested ketone level when treating depression. Blood ketone target for psychotic disorders/bipolar disorder: >1.5 mmol - Palmer’s preferred ketone level for psychotic disorders and bipolar disorder. Historical origin of ketogenic diet: 1921 - Developed by a physician at the Mayo Clinic to treat epilepsy. Early epilepsy outcomes: 50% seizure-free; 35% had >50% reduction - Palmer cites early ketogenic diet results in epilepsy. Overall early epilepsy efficacy: ~85% - Combined early response rate from seizure-free plus major reduction groups. Treatment-resistant epilepsy prevalence: ~30% - Proportion of epilepsy patients who do not respond to current treatments. Johns Hopkins treatment-resistant epilepsy outcome: ~1/3 seizure-free; ~1/3 with clinical benefit - Outcomes for refractory epilepsy patients on ketogenic diet. Number of psychiatric medications tried by schizoaffective patient: 17 - The patient had failed 17 different medications before ketogenic therapy. Weight loss in schizoaffective patient: 160 pounds - The patient lost 160 pounds and maintained it. Duration of inpatient/outpatient treatment for severe patient: 8 years - Palmer had followed the schizoaffective patient for eight years. AG1 usage claim: nearly 14 years - Huberman says he has taken AG1 daily for nearly 14 years. 8 Sleep usage claim: nearly 5 years - Huberman says he has slept on an 8 Sleep mattress cover for nearly five years. BetterHelp rating: 4.9/5 - Huberman cites BetterHelp’s average live-session rating. BetterHelp review count: over 1.7 million - Number of client reviews cited for BetterHelp.

Pivotal Quotes: "Within three months, my metabolic syndrome was completely gone." — Dr. Chris Palmer: Palmer describing his own response to the Atkins diet after years of worsening metabolic syndrome. "The thing that completely upended everything that I knew as a psychiatrist was six to eight weeks in, he spontaneously starts reporting, you know, those voices that I hear all the time? They're going away." — Dr. Chris Palmer: Palmer describing the schizoaffective patient’s improvement on ketogenic diet. "I believe once you understand the science of mitochondria, you can actually connect all of the dots of the mental illness puzzle." — Dr. Chris Palmer: Palmer explaining his mechanistic framework for metabolic psychiatry.

Implications: Listeners may view diet as a serious lever for brain health, not just weight control. The discussion suggests future psychiatry may integrate metabolic assessment, carbohydrate restriction, and ketogenic therapy alongside medication, especially for difficult-to-treat cases.